Ryan Gerbrandt - May 20, 2025 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Chief Operating Officer
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
May 20, 2025
Transactions value $
$0
Form type
4
Date filed
5/22/2025, 03:20 PM
Previous filing
May 20, 2025
Next filing
Jul 15, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gerbrandt Ryan Chief Operating Officer 3 GARRET MOUNTAIN PLAZA, SUITE 401, WOODLAND PARK s/ Gena L. Ashe, Attorney-in-Fact 2025-05-22 0001821509

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +53.5K $0.00 53.5K May 20, 2025 Common Stock 53.5K $34.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.